Concepedia

Matthew J. Sheetz

MJ

Statistics

Publications

18

Citations

1.1K

H-Index

15

Active since

1988

Affiliations

Eli Lilly (United States)(Current)

Joslin Diabetes Center

Harvard University

University of Wisconsin–Madison

Eli Lilly (United Kingdom)

Matthew J. Sheetz is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and diabetology.

Publications per year

1988–2019

18

Publications

18

Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy

James R. Voelker, Paul H. Berg, Matthew J. Sheetz et al. · Journal of the American Society of Nephrology · 2016 · 273 citations

, , +17

Splenomegaly in Dogs

Kenneth A. Johnson, B. E. Powers, S. J. Withrow et al. · Journal of Veterinary Internal Medicine · 1989 · 152 citations · Full text

, , +15

ORAL PROTEIN KINASE C β INHIBITION USING RUBOXISTAURIN

Lloyd Paul Aiello, Louis Vignati, Matthew J. Sheetz et al. · Retina · 2011 · 96 citations

, , +17

Effect of Ruboxistaurin on the Visual Acuity Decline Associated with Long-standing Diabetic Macular Edema

Matthew D. Davis, Matthew J. Sheetz, Lloyd Paul Aiello et al. · Investigative Ophthalmology & Visual Science · 2009 · 87 citations · Full text

, , +17

Targeting the hepcidin–ferroportin pathway in anaemia of chronic kidney disease

Matthew J. Sheetz, Philip Barrington, Sophie Callies et al. · British Journal of Clinical Pharmacology · 2019 · 75 citations · Full text

, , +17

1–5 of 18